Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 002005499753 cql: author exact 801000624089

Add to list
- Journal Article
- A1
- open access
MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation

Anneleen Beckers (UGent) , Gert Van Peer (UGent) , Daniel R Carter, Kristina Althoff, Belamy B Cheung, Johannes H Schulte, Pieter Mestdagh (UGent) , Jo Vandesompele (UGent) , Glenn M Marshall, Katleen De Preter (UGent) , et al.

(2015) ONCOTARGET. 6(7). p.5204-5216
Add to list
- Conference Paper
- C3
ETV5 functionally connect ALK and RET signaling in neuroblastoma

Irina Lambertz (UGent) , Shana Claeys (UGent) , Candy Kumps (UGent) , Liselot Mus (UGent) , Anneleen Beckers (UGent) , Els Janssens, Nadine Van Roy (UGent) , Genevieve Laureys (UGent) , Johannes Schulte, Olivier De Wever (UGent) , et al.

(2015) Combined SIOPEN annual general meeting and 4th Neuroblastoma Research symposium, Abstracts.
Add to list
- Conference Paper
- C3
SOX11 is a lineage-survival oncogene in neuroblastoma

Sara De Brouwer (UGent) , Bieke Decaesteker (UGent) , Anneleen Beckers (UGent) , Genevieve Laureys (UGent) , Monique Morrison, Rodney Stewart, Franki Speleman (UGent) and Katleen De Preter (UGent)

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
Time-resolved transcriptome analysis of TH-MYCN driven hyperplastic ganglia and tumors marks BRD3 as a novel candidate oncogene

Anneleen Beckers (UGent) , Daniel Carter, Cheung Belamy, Jo Vandesompele (UGent) , Glen Marshall, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
SOX11 is a lineage-survival oncogene in neuroblastoma

Bieke Decaesteker (UGent) , Sara De Brouwer (UGent) , Anneleen Beckers (UGent) , Genevieve Laureys (UGent) , Monique Morrison, Rodney Stewart, Franki Speleman (UGent) and Katleen De Preter (UGent)

(2014) Translational genetics : from cage over bench to bed. p.77-77
Add to list
- Conference Paper
- C3
SOX11 is a lineage-survival oncogene in neuroblastoma

Bieke Decaesteker (UGent) , Sara De Brouwer (UGent) , Anneleen Beckers (UGent) , Rodney Stewart, Franki Speleman (UGent) and Katleen De Preter (UGent)

(2014) OncoPoint, 2nd Meeting, Abstracts. p.11-11
Add to list
- Conference Paper
- C3
Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindler, Anneleen Beckers (UGent) , Els Janssens (UGent) , Marilena De Mariano, Sara De Brouwer (UGent) , Jay Gibbons, Genevieve Laureys (UGent) , et al.

(2014) Cancer Pharmacogenomics and Targeted Therapies, 2nd Wellcom Trust conference, Abstracts.
Add to list
- Conference Paper
- C3
The MYCN/miR-26a-5p/LIN28B regulatory axis controls MYCN-driven LIN28B upregulation in neuroblastoma

Anneleen Beckers (UGent) , Andrew Ludwig, Gert Van Peer (UGent) , Daniel Carter, Belamy Cheung, Sara De Brouwer (UGent) , Jo Vandesompele (UGent) , Katleen De Preter (UGent) , Jason Shohet and Franki Speleman (UGent)

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
Promoter DNA-methylation in the TH-MYCN neuroblastoma mouse model

Anneleen Beckers (UGent) , Wouter Van Loocke (UGent) , Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jo Vandesompele (UGent) , Franki Speleman (UGent) and Katleen De Preter (UGent)

(2014) ANR Cologne 2014 : information book.
Add to list
- Conference Paper
- C3
MYCN safeguards its upregulated expression through negatively controlling its upstream miRNAs

Anneleen Beckers (UGent) , Gert Van Peer (UGent) , Daniel Carter, Belamy Cheung, Jo Vandesompele (UGent) , Glenn Marshall, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2014) ANR Cologne 2014 : information book.

← Previous

Academic Bibliography

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation

ETV5 functionally connect ALK and RET signaling in neuroblastoma

SOX11 is a lineage-survival oncogene in neuroblastoma

Time-resolved transcriptome analysis of TH-MYCN driven hyperplastic ganglia and tumors marks BRD3 as a novel candidate oncogene

SOX11 is a lineage-survival oncogene in neuroblastoma

SOX11 is a lineage-survival oncogene in neuroblastoma

Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma

The MYCN/miR-26a-5p/LIN28B regulatory axis controls MYCN-driven LIN28B upregulation in neuroblastoma

Promoter DNA-methylation in the TH-MYCN neuroblastoma mouse model

MYCN safeguards its upregulated expression through negatively controlling its upstream miRNAs

Contents

Support

Contact